These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 15972087)
1. Ethnic differences in pain among outpatients with terminal and end-stage chronic illness. Rabow MW; Dibble SL Pain Med; 2005; 6(3):235-41. PubMed ID: 15972087 [TBL] [Abstract][Full Text] [Related]
2. The comprehensive care team: a controlled trial of outpatient palliative medicine consultation. Rabow MW; Dibble SL; Pantilat SZ; McPhee SJ Arch Intern Med; 2004 Jan; 164(1):83-91. PubMed ID: 14718327 [TBL] [Abstract][Full Text] [Related]
3. Codeine/acetaminophen and hydrocodone/acetaminophen combination tablets for the management of chronic cancer pain in adults: a 23-day, prospective, double-blind, randomized, parallel-group study. Rodriguez RF; Castillo JM; Del Pilar Castillo M; Nuñez PD; Rodriguez MF; Restrepo JM; Rodriguez JM; Ortiz Y; Angel AM Clin Ther; 2007 Apr; 29(4):581-7. PubMed ID: 17617281 [TBL] [Abstract][Full Text] [Related]
4. The effects of analgesic prescription and patient adherence on pain in a dutch outpatient cancer population. Enting RH; Oldenmenger WH; Van Gool AR; van der Rijt CC; Sillevis Smitt PA J Pain Symptom Manage; 2007 Nov; 34(5):523-31. PubMed ID: 17664055 [TBL] [Abstract][Full Text] [Related]
5. Anthroposophic medical therapy in chronic disease: a four-year prospective cohort study. Hamre HJ; Witt CM; Glockmann A; Ziegler R; Willich SN; Kiene H BMC Complement Altern Med; 2007 Apr; 7():10. PubMed ID: 17451595 [TBL] [Abstract][Full Text] [Related]
6. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study. Simpson DM; Messina J; Xie F; Hale M Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282 [TBL] [Abstract][Full Text] [Related]
7. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626 [TBL] [Abstract][Full Text] [Related]
8. The use of medication for chronic pain in primary care, and the potential for intervention by a practice-based pharmacist. McDermott ME; Smith BH; Elliott AM; Bond CM; Hannaford PC; Chambers WA Fam Pract; 2006 Feb; 23(1):46-52. PubMed ID: 16107494 [TBL] [Abstract][Full Text] [Related]
9. Knowledge and beliefs about end-of-life care and the effects of specialized palliative care: a population-based survey in Japan. Morita T; Miyashita M; Shibagaki M; Hirai K; Ashiya T; Ishihara T; Matsubara T; Miyoshi I; Nakaho T; Nakashima N; Onishi H; Ozawa T; Suenaga K; Tajima T; Akechi T; Uchitomi Y J Pain Symptom Manage; 2006 Apr; 31(4):306-16. PubMed ID: 16632078 [TBL] [Abstract][Full Text] [Related]
10. Assessment of dosing frequency of sustained-release opioid preparations in patients with chronic nonmalignant pain. Gallagher RM; Welz-Bosna M; Gammaitoni A Pain Med; 2007; 8(1):71-4. PubMed ID: 17244106 [TBL] [Abstract][Full Text] [Related]
11. Prescribing of pain medication in palliative care. A survey in general practice. Borgsteede SD; Deliens L; Zuurmond WW; Schellevis FG; Willems DL; Van der Wal G; van Eijk JT Pharmacoepidemiol Drug Saf; 2009 Jan; 18(1):16-23. PubMed ID: 18985638 [TBL] [Abstract][Full Text] [Related]
12. Controlled substance abuse and illicit drug use in chronic pain patients: An evaluation of multiple variables. Manchikanti L; Cash KA; Damron KS; Manchukonda R; Pampati V; McManus CD Pain Physician; 2006 Jul; 9(3):215-25. PubMed ID: 16886030 [TBL] [Abstract][Full Text] [Related]
13. Changes in the prescribed daily doses of transdermal fentanyl and transdermal buprenorphine during treatment of patients with cancer and noncancer pain in Germany: results of a retrospective cohort study. Sittl R; Nuijten M; Nautrup BP Clin Ther; 2005 Jul; 27(7):1022-31. PubMed ID: 16154481 [TBL] [Abstract][Full Text] [Related]
14. Transdermal buprenorphine in clinical practice--a post-marketing surveillance study in 13,179 patients. Griessinger N; Sittl R; Likar R Curr Med Res Opin; 2005 Aug; 21(8):1147-56. PubMed ID: 16083522 [TBL] [Abstract][Full Text] [Related]
15. Oxymorphone extended release for the treatment of chronic low back pain: a retrospective pooled analysis of enriched-enrollment clinical trial data stratified according to age, sex, and prior opioid use. Peniston JH; Gould E Clin Ther; 2009 Feb; 31(2):347-59. PubMed ID: 19302907 [TBL] [Abstract][Full Text] [Related]
16. Has pain management in cancer patients with bone metastases improved? A seven-year review at an outpatient palliative radiotherapy clinic. Kirou-Mauro AM; Hird A; Wong J; Sinclair E; Barnes EA; Tsao M; Danjoux C; Chow E J Pain Symptom Manage; 2009 Jan; 37(1):77-84. PubMed ID: 18504094 [TBL] [Abstract][Full Text] [Related]
17. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison. Likar R; Lorenz V; Korak-Leiter M; Kager I; Sittl R Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542 [TBL] [Abstract][Full Text] [Related]
20. Association of age with analgesic use for back and joint disorders in outpatient settings. Federman AD; Litke A; Morrison RS Am J Geriatr Pharmacother; 2006 Dec; 4(4):306-15. PubMed ID: 17296536 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]